03000nas a2200397 4500008004100000022001400041245010600055210006900161260001300230300001000243490000700253520190400260653000902164653002202173653001002195653001002205653001102215653001502226653001102241653001702252653002302269653002502292653000902317653001902326653001702345653002102362100002202383700002402405700002702429700002402456700001902480700002402499700002302523700002102546856003502567 2002 eng d a0895-706100aCorrelates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study.0 aCorrelates of aortic stiffness in elderly individuals a subgroup c2002 Jan a16-230 v153 a
BACKGROUND: Arterial stiffness has been associated with aging, hypertension, and diabetes; however, little data has been published examining risk factors associated with arterial stiffness in elderly individuals.
METHODS: Longitudinal associations were made between aortic stiffness and risk factors measured approximately 4 years earlier. Aortic pulse wave velocity (PWV), an established index of arterial stiffness, was measured in 356 participants (53.4% women, 25.3% African American), aged 70 to 96 years, from the Pittsburgh site of the Cardiovascular Health Study during 1996 to 1998.
RESULTS: Mean aortic pulse wave velocity (850 cm/sec, range 365 to 1863) did not differ by ethnicity or sex. Increased aortic stiffness was positively associated with higher systolic blood pressure (SBP), age, fasting and 2-h postload glucose, fasting and 2-h insulin, triglycerides, waist circumference, body mass index, truncal fat, decreased physical activity, heart rate, and common carotid artery wall thickness (P < .05). After controlling for age and SBP, the strongest predictors of aortic stiffness in men were heart rate (P = .001) and 2-h glucose (P = .063). In women, PWV was positively associated with heart rate (P = .018), use of antihypertensive medication (P = .035), waist circumference (P = .030), and triglycerides (P = .081), and was negatively associated with physical activity (P = .111). Results were similar when the analysis was repeated in nondiabetic individuals and in those free of clinical or subclinical cardiovascular disease in 1992 to 1993.
CONCLUSIONS: In these elderly participants, aortic stiffness was positively associated with risk factors associated with the insulin resistance syndrome, increased common carotid intima-media thickness, heart rate, and decreased physical activity measured several years earlier.
10aAged10aAged, 80 and over10aAging10aAorta10aFemale10aHeart Rate10aHumans10aHypertension10aInsulin Resistance10aLongitudinal Studies10aMale10aPulsatile Flow10aRisk Factors10aSex Distribution1 aMackey, Rachel, H1 aSutton-Tyrrell, Kim1 aVaitkevicius, Peter, V1 aSakkinen, Pamela, A1 aLyles, Mary, F1 aSpurgeon, Harold, A1 aLakatta, Edward, G1 aKuller, Lewis, H uhttps://chs-nhlbi.org/node/67702931nas a2200469 4500008004100000022001400041245005800055210005700113260001600170300001100186490000800197520172200205653000901927653001201936653002401948653002301972653001901995653001202014653000902026653001702035653002502052653001402077653001102091653002202102653001102124653001402135653001802149653003202167653002402199653000902223653001202232653000902244100002502253700002002278700001802298700002402316700002202340700001902362700002102381700002402402856003502426 2004 eng d a1524-453900aFish intake and risk of incident atrial fibrillation.0 aFish intake and risk of incident atrial fibrillation c2004 Jul 27 a368-730 v1103 aBACKGROUND: Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and is particularly common in the elderly. Although effects of fish intake, including potential antiarrhythmic effects, may favorably influence risk of AF, relationships between fish intake and AF incidence have not been evaluated.
METHODS AND RESULTS: In a prospective, population-based cohort of 4815 adults > or =age 65 years, usual dietary intake was assessed at baseline in 1989 and 1990. Consumption of tuna and other broiled or baked fish correlated with plasma phospholipid long-chain n-3 fatty acids, whereas consumption of fried fish or fish sandwiches (fish burgers) did not. AF incidence was prospectively ascertained on the basis of hospital discharge records and annual electrocardiograms. During 12 years' follow-up, 980 cases of incident AF were diagnosed. In multivariate analyses, consumption of tuna or other broiled or baked fish was inversely associated with incidence of AF, with 28% lower risk with intake 1 to 4 times per week (HR=0.72, 95% CI=0.58 to 0.91, P=0.005), and 31% lower risk with intake > or =5 times per week (HR=0.69, 95% CI=0.52 to 0.91, P=0.008), compared with <1 time per month (P trend=0.004). Results were not materially different after adjustment for preceding myocardial infarction or congestive heart failure. In similar analyses, fried fish/fish sandwich consumption was not associated with lower risk of AF.
CONCLUSIONS: Among elderly adults, consumption of tuna or other broiled or baked fish, but not fried fish or fish sandwiches, is associated with lower incidence of AF. Fish intake may influence risk of this common cardiac arrhythmia.
10aAged10aAnimals10aAtrial Fibrillation10aCardiotonic Agents10aCohort Studies10aCooking10aDiet10aDietary Fats10aFatty Acids, Omega-310aFish Oils10aFishes10aFollow-Up Studies10aHumans10aIncidence10aMassachusetts10aProportional Hazards Models10aProspective Studies10aRisk10aSeafood10aTuna1 aMozaffarian, Dariush1 aPsaty, Bruce, M1 aRimm, Eric, B1 aLemaitre, Rozenn, N1 aBurke, Gregory, L1 aLyles, Mary, F1 aLefkowitz, David1 aSiscovick, David, S uhttps://chs-nhlbi.org/node/79702906nas a2200373 4500008004100000022001400041245013100055210006900186260001300255300001200268490000700280520184800287653000902135653002202144653001402166653001602180653002702196653001102223653002002234653001102254653000902265653001402274653001402288653002402302653004002326653001702366653001202383100002202395700001602417700002402433700001902457700002102476856003502497 2005 eng d a0002-861400aHospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival.0 aHospitalization for pneumonia in the Cardiovascular Health Study c2005 Jul a1108-160 v533 aOBJECTIVES: To estimate the rate of hospitalization for pneumonia in community-dwelling older adults and to assess its risk factors and contribution to mortality.
DESIGN: Prospective observational study.
SETTING: The Cardiovascular Health Study (CHS) in four U.S. communities.
PARTICIPANTS: Five thousand eight hundred eighty-eight men and women aged 65 and older who were followed for a median 10.7 years.
MEASUREMENTS: Participants were interviewed about medical history and demographics; evaluated for lung, physical, and cognitive function; and followed for hospitalizations, cardiovascular disease, and death.
RESULTS: Nearly 10% of the cohort was hospitalized for pneumonia, for a rate of 11.1 per 1,000 person-years (95% confidence interval (CI)=10.2-12.0). Risk factors included older age, male sex, current and past smoking, poor physical and lung function, and history of cardiovascular disease and chronic obstructive pulmonary disease. Ten percent of participants died during their incident pneumonia hospitalization, and death rates were high in those who survived to discharge. Compared with participants who had not been hospitalized for pneumonia, the relative risk of total mortality was 4.9 (95% CI=4.1-6.0) during the first year after hospitalization and 2.6 (95% CI=2.2-3.1) thereafter, adjusted for age, sex, and race. The respective relative risks were 3.9 (95% CI=3.1-4.8) and 2.0 (95% CI=1.6-2.4) after further adjustment for baseline history of cardiovascular disease; diabetes mellitus; smoking; and measures of lung, physical, and cognitive function.
CONCLUSION: In older people, hospitalization for pneumonia is common and is associated with an elevated risk of death, as shown in this population-based, prospective cohort.
10aAged10aAged, 80 and over10aCognition10aComorbidity10aDiabetes Complications10aFemale10aHospitalization10aHumans10aMale10aMortality10aPneumonia10aProspective Studies10aRespiratory Physiological Phenomena10aRisk Factors10aSmoking1 aO'Meara, Ellen, S1 aWhite, Mark1 aSiscovick, David, S1 aLyles, Mary, F1 aKuller, Lewis, H uhttps://chs-nhlbi.org/node/85302874nas a2200409 4500008004100000022001400041245014200055210006900197260001300266300001400279490000700293520165500300653000901955653002201964653004501986653001102031653001802042653001802060653001102078653001702089653000902106653002602115653003602141653002402177653002402201653001802225653001602243100002602259700002302285700002302308700001902331700001902350700002102369700001902390700002002409856003502429 2005 eng d a0002-861400aWeight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension.0 aWeight loss muscle strength and angiotensinconverting enzyme inh c2005 Nov a1996-20000 v533 aOBJECTIVES: To determine whether angiotensin-converting enzyme (ACE) inhibitor use may be associated with weight maintenance and sustained muscle strength (measured by grip strength) in older adults.
DESIGN: Data from the Cardiovascular Health Study (CHS), a community-based prospective cohort study of 5,888 older adults, were used.
SETTING: Subjects were recruited from four U.S. sites beginning in 1989; this analysis included data through 2001.
PARTICIPANTS: CHS participants with congestive heart failure (CHF) or treated hypertension.
MEASUREMENTS: The exposure, current ACE inhibitor use, was ascertained by medication inventory at annual clinic visits; the outcomes were weight change and grip-strength change during the following year. Multivariate linear regression was used, accounting for correlations between observations on the same participant over time.
RESULTS: The average annual weight change was -0.38 kg in 2,834 participants (14,443 person-years) with treated hypertension and -0.62 kg in 342 participants (980 person-years) with CHF. ACE inhibitor use was associated with less annual weight loss after adjustment for potential confounders: a difference of 0.17 kg (95% confidence interval (CI)=0.05-0.29) in those with treated hypertension and 0.29 kg (95% CI=-0.25-0.83) in those with CHF. There was no evidence of association between ACE inhibitor use and grip-strength change.
CONCLUSION: ACE inhibitor use may be associated with weight maintenance, but not maintenance of muscle strength, in older adults with treated hypertension.
10aAged10aAged, 80 and over10aAngiotensin-Converting Enzyme Inhibitors10aFemale10aHand Strength10aHeart Failure10aHumans10aHypertension10aMale10aMultivariate Analysis10aOutcome Assessment, Health Care10aProspective Studies10aStatistics as Topic10aUnited States10aWeight Loss1 aSchellenbaum, Gina, D1 aSmith, Nicholas, L1 aHeckbert, Susan, R1 aLumley, Thomas1 aRea, Thomas, D1 aFurberg, Curt, D1 aLyles, Mary, F1 aPsaty, Bruce, M uhttps://chs-nhlbi.org/node/86803039nas a2200385 4500008004100000022001400041245012600055210006900181260001300250300001100263490000700274520189100281653002102172653000902193653002202202653002802224653002402252653001102276653002202287653002502309653002002334653001102354653000902365653002702374653002502401653003202426653002002458653001702478653003102495100002402526700002002550700001902570700002802589856003602617 2010 eng d a1758-535X00aCognition and the risk of hospitalization for serious falls in the elderly: results from the Cardiovascular Health Study.0 aCognition and the risk of hospitalization for serious falls in t c2010 Nov a1242-90 v653 aBACKGROUND: Many elderly adults fall every year, sometimes resulting in serious injury and hospitalization. Although impaired cognition is a risk factor for injurious falls, little is known about cognitive decline above the threshold of impairment and risk of serious falls in community-dwelling seniors.
METHODS: In total, 702 of 5,356 older adults participating in the Cardiovascular Health Study experienced an injurious fall between 1990 and 2005, as indicated by hospitalization records. General cognition was measured annually with the Modified Mini-Mental State Examination and processing speed with the Digit Symbol Substitution Test. The Cox regression model was used to calculate hazard ratio and 95% confidence interval with and without time-dependent covariates and adjusted for known risk factors.
RESULTS: Participants with slightly decreased Digit Symbol Substitution Test scores were at increased risk for a serious fall (hazard ratio = 1.58, 95% confidence interval = 1.15-2.17). The risk continued to increase with each quartile decrease in Digit Symbol Substitution Test score. Participants without prevalent cardiovascular disease at baseline and decreased Modified Mini-Mental State Examination scores (80-89) had a 45% increased risk for a serious fall and those at high risk for dementia (<80) were at twice the risk as participants scoring above 90 (hazard ratio = 2.16, 95% confidence interval = 1.60-2.91).
CONCLUSIONS: Both decreased general cognition and decreased processing speed appear to be potential risk factors for serious falls in the elderly. When assessing the risk of serious falls in elderly patients, clinicians should consider usual factors like gait instability and sensory impairment as well as less obvious ones such as cardiovascular disease and cognitive function in nondemented adults.
10aAccidental Falls10aAged10aAged, 80 and over10aChi-Square Distribution10aCognition Disorders10aFemale10aFollow-Up Studies10aGeriatric Assessment10aHospitalization10aHumans10aMale10aMental Status Schedule10aPhysical Examination10aProportional Hazards Models10aRisk Assessment10aRisk Factors10aSurveys and Questionnaires1 aWelmerink, Diana, B1 aLongstreth, W T1 aLyles, Mary, F1 aFitzpatrick, Annette, L uhttps://chs-nhlbi.org/node/121203607nas a2200433 4500008004100000022001400041245010100055210006900156260001600225300001100241490000800252520240100260653000902661653002002670653002802690653001902718653001602737653001102753653002002764653001102784653000902795653001602804653001402820653001702834100003202851700002302883700002302906700002002929700002302949700002502972700001702997700001703014700002103031700002403052700001903076700002403095700001803119856003603137 2015 eng d a1538-359800aAssociation between hospitalization for pneumonia and subsequent risk of cardiovascular disease.0 aAssociation between hospitalization for pneumonia and subsequent c2015 Jan 20 a264-740 v3133 aIMPORTANCE: The risk of cardiovascular disease (CVD) after infection is poorly understood.
OBJECTIVE: To determine whether hospitalization for pneumonia is associated with an increased short-term and long-term risk of CVD.
DESIGN, SETTINGS, AND PARTICIPANTS: We examined 2 community-based cohorts: the Cardiovascular Health Study (CHS, n = 5888; enrollment age, ≥65 years; enrollment period, 1989-1994) and the Atherosclerosis Risk in Communities study (ARIC, n = 15,792; enrollment age, 45-64 years; enrollment period, 1987-1989). Participants were followed up through December 31, 2010. We matched each participant hospitalized with pneumonia to 2 controls. Pneumonia cases and controls were followed for occurrence of CVD over 10 years after matching. We estimated hazard ratios (HRs) for CVD at different time intervals, adjusting for demographics, CVD risk factors, subclinical CVD, comorbidities, and functional status.
EXPOSURES: Hospitalization for pneumonia.
MAIN OUTCOMES AND MEASURES: Incident CVD (myocardial infarction, stroke, and fatal coronary heart disease).
RESULTS: Of 591 pneumonia cases in CHS, 206 had CVD events over 10 years after pneumonia hospitalization. CVD risk after pneumonia was highest in the first year. CVD occurred in 54 cases and 6 controls in the first 30 days (HR, 4.07; 95% CI, 2.86-5.27); 11 cases and 9 controls between 31 and 90 days (HR, 2.94; 95% CI, 2.18-3.70); and 22 cases and 55 controls between 91 days and 1 year (HR, 2.10; 95% CI, 1.59-2.60). Additional CVD risk remained elevated into the tenth year, when 4 cases and 12 controls developed CVD (HR, 1.86; 95% CI, 1.18-2.55). In ARIC, of 680 pneumonia cases, 112 had CVD over 10 years after hospitalization. CVD occurred in 4 cases and 3 controls in the first 30 days (HR, 2.38; 95% CI, 1.12-3.63); 4 cases and 0 controls between 31 and 90 days (HR, 2.40; 95% CI, 1.23-3.47); 11 cases and 8 controls between 91 days and 1 year (HR, 2.19; 95% CI, 1.20-3.19); and 8 cases and 7 controls during the second year (HR, 1.88; 95% CI, 1.10-2.66). After the second year, the HRs were no longer statistically significant.
CONCLUSIONS AND RELEVANCE: Hospitalization for pneumonia was associated with increased short-term and long-term risk of CVD, suggesting that pneumonia may be a risk factor for CVD.
10aAged10aAtherosclerosis10aCardiovascular Diseases10aCohort Studies10aComorbidity10aFemale10aHospitalization10aHumans10aMale10aMiddle Aged10aPneumonia10aRisk Factors1 aCorrales-Medina, Vicente, F1 aAlvarez, Karina, N1 aWeissfeld, Lisa, A1 aAngus, Derek, C1 aChirinos, Julio, A1 aChang, Chung-Chou, H1 aNewman, Anne1 aLoehr, Laura1 aFolsom, Aaron, R1 aElkind, Mitchell, S1 aLyles, Mary, F1 aKronmal, Richard, A1 aYende, Sachin uhttps://chs-nhlbi.org/node/666903088nas a2200457 4500008004100000022001400041245011800055210006900173260001300242300001100255490000800266520180100274653000902075653002402084653001102108653002202119653001602141653001802157653002002175653001102195653001402206653001502220653000902235653002402244653001402268653003202282653002602314653002002340653001702360653001702377100003202394700002102426700001802447700002102465700002002486700002002506700002602526700001902552700002302571856003602594 2015 eng d a1097-674400aIntermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults.0 aIntermediate and longterm risk of newonset heart failure after h c2015 Aug a306-120 v1703 aBACKGROUND: Pneumonia is associated with high risk of heart failure (HF) in the short term (30 days) postinfection. Whether this association persists beyond this period is unknown.
METHODS: We studied 5,613 elderly (≥65 years) adults enrolled in the Cardiovascular Health Study between 1989 and 1994 at 4 US communities. Participants had no clinical diagnosis of HF at enrollment, and they were followed up through December 2010. Hospitalizations for pneumonia were identified using validated International Classification of Disease Ninth Revision codes. A centralized committee adjudicated new-onset HF events. Using Cox regression, we estimated adjusted hazard ratios (HRs) of new-onset HF at different time intervals after hospitalization for pneumonia.
RESULTS: A total of 652 participants hospitalized for pneumonia during follow-up were still alive and free of clinical diagnosis of HF by day 30 posthospitalization. Relative to the time of their hospitalization, new-onset HF occurred in 22 cases between 31 and 90 days (HR 6.9, 95% CI 4.46-10.63, P < .001), 14 cases between 91 days and 6 months (HR 3.2, 95% CI 1.88-5.50, P < .001), 20 cases between 6 months and 1 year (HR 2.6, 95% CI 1.64-4.04, P < .001), 76 cases between 1 and 5 years (HR 1.7, 95% CI 1.30-2.12, P < .001), and 71 cases after 5 years (HR 2.0, 95% CI 1.56-2.58, P < .001). Results were robust to sensitivity analyses using stringent definitions of pneumonia and extreme assumptions for potential informative censoring.
CONCLUSION: Hospitalization for pneumonia is associated with increased risk of new-onset HF in the intermediate and long term. Studies should characterize the mechanisms of this association in order to prevent HF in elderly pneumonia survivors.
10aAged10aDisease Progression10aFemale10aFollow-Up Studies10aForecasting10aHeart Failure10aHospitalization10aHumans10aIncidence10aInpatients10aMale10aPatient Readmission10aPneumonia10aProportional Hazards Models10aRetrospective Studies10aRisk Assessment10aRisk Factors10aTime Factors1 aCorrales-Medina, Vicente, F1 aTaljaard, Monica1 aYende, Sachin1 aKronmal, Richard1 aDwivedi, Girish1 aNewman, Anne, B1 aElkind, Mitchell, S V1 aLyles, Mary, F1 aChirinos, Julio, A uhttps://chs-nhlbi.org/node/680802786nas a2200229 4500008004100000022001400041245010500055210006900160260001300229300001000242490000700252520207700259100002902336700001902365700002302384700002502407700002502432700001902457700002202476700002202498856003602520 2019 eng d a1532-541500aAbnormal Fasting Glucose Increases Risk of Unrecognized Myocardial Infarctions in an Elderly Cohort.0 aAbnormal Fasting Glucose Increases Risk of Unrecognized Myocardi c2019 Jan a43-490 v673 aOBJECTIVES: To investigate glucose levels as a risk factor for unrecognized myocardial infarctions (UMIs).
DESIGN: Cohort SETTING: Cardiovascular Health Study.
PARTICIPANTS: Individuals aged 65 and older with fasting glucose measurements (N=4,355; normal fasting glucose (NFG), n = 2,041; impaired fasting glucose (IFG), n = 1,706; DM: n = 608; 40% male, 84% white, mean age 72.4 ± 5.6).
MEASUREMENTS: The relationship between glucose levels and UMI was examined. Participants with prior coronary heart disease (CHD) or UMI on initial electrocardiography were excluded. Using Minnesota codes, UMI was identified according to the presence of pathological Q-waves or minor Q-waves with ST-T abnormalities. Crude and adjusted hazard ratios (HRs) were calculated. Analyses were adjusted for age, sex, body mass index (BMI), hypertension, antihypertensive and lipid-lowering medication use, total cholesterol, high-density lipoprotein cholesterol, and smoking status.
RESULTS: Over a mean follow-up of 6 years, there were 459 incident UMIs (NFG, n=202; IFG, n=183; DM, n=74). Participants with IFG were slightly more likely than those with NFG to experience a UMI (hazard ratio (HR)=1.11, 95% confidence interval (CI)=0.91-1.36, p = .30), and those with DM were more likely than those with NFG to experience a UMI (HR=1.65, 95% CI=1.25-2.13, p < .001). After adjustment HR for UMI in IFG those with IFG were no more likely than those with NFG to experience a UMI (HR=1.01, 95% CI=0.82-1.24, p = .93), whereas those with DM were more likely than those with NFG to experience a UMI (HR=1.37, 95% CI=1.02-1.81, p = .03). The 2-hour oral glucose tolerance test was not statistically significantly associated with UMI.
CONCLUSION: Fasting glucose status, particularly in the diabetic range, forecasted UMI during 6 years of follow-up in elderly adults. Further studies are needed to clarify the level of glucose at which risk is greater. J Am Geriatr Soc 67:43-49, 2019.
1 aStacey, Richard, Brandon1 aZgibor, Janice1 aLeaverton, Paul, E1 aSchocken, Douglas, D1 aPeregoy, Jennifer, A1 aLyles, Mary, F1 aBertoni, Alain, G1 aBurke, Gregory, L uhttps://chs-nhlbi.org/node/792502360nas a2200229 4500008004100000022001400041245010200055210006900157260001600226300001200242490000600254520167100260100002001931700001901951700001901970700002001989700001902009700002402028700001802052700002402070856003602094 2020 eng d a2047-998000aFatty Acid Binding Protein-4 and Risk of Cardiovascular Disease: The Cardiovascular Health Study.0 aFatty Acid Binding Protein4 and Risk of Cardiovascular Disease T c2020 Apr 07 ae0140700 v93 aBackground FABP-4 (fatty acid binding protein-4) is a lipid chaperone in adipocytes and has been associated with prognosis in selected clinical populations. We investigated the associations between circulating FABP-4, risk of incident cardiovascular disease (CVD), and risk of CVD mortality among older adults with and without established CVD. Methods and Results In the Cardiovascular Health Study, we measured FABP4 levels in stored specimens from the 1992-993 visit and followed participants for incident CVD if they were free of prevalent CVD at baseline and for CVD mortality through June 2015. We used Cox regression to estimate hazard ratios for incident CVD and CVD mortality per doubling in serum FABP-4 adjusted for age, sex, race, field center, waist circumference, blood pressure, lipids, fasting glucose, and C-reactive protein. Among 4026 participants free of CVD and 681 with prevalent CVD, we documented 1878 cases of incident CVD and 331 CVD deaths, respectively. In adjusted analyses, FABP-4 was modestly associated with risk of incident CVD (mean, 34.24; SD, 18.90; HR, 1.10 per doubling in FABP-4, 95% CI, 1.00-1.21). In contrast, FABP-4 was more clearly associated with risk of CVD mortality among participants without (HR hazard ratio 1.24, 95% CI, 1.10-1.40) or with prevalent CVD (HR hazard ratio 1.57, 95% CI, 1.24-1.98). These associations were not significantly modified by sex, age, and waist circumference. Conclusions Serum FABP-4 is modestly associated with risk of incident CVD even after adjustment for standard risk factors, but more strongly associated with CVD mortality among older adults with and without established CVD.
1 aEgbuche, Obiora1 aBiggs, Mary, L1 aIx, Joachim, H1 aKizer, Jorge, R1 aLyles, Mary, F1 aSiscovick, David, S1 aDjoussé, Luc1 aMukamal, Kenneth, J uhttps://chs-nhlbi.org/node/836903815nas a2200229 4500008004100000022001400041245017500055210006900230260001600299300001000315490000800325520304400333100001703377700002503394700002003419700001903439700002003458700002503478700002203503700002403525856003603549 2021 eng d a1879-191300aIncidence, Determinants and Mortality of Heart Failure Associated With Medical-Surgical Procedures in Patients ≥ 65 Years of Age (from the Cardiovascular Health Study).0 aIncidence Determinants and Mortality of Heart Failure Associated c2021 Aug 15 a71-780 v1533 aHeart failure (HF) and myocardial infarction are serious complications of major noncardiac surgery in older adults. Many factors can contribute to the development of HF during the postoperative period. The incidence of, and risk factors for, procedure-associated heart failure (PHF) occurring at the time of, or shortly after, medical procedures in a population-based sample ≥ 65 years of age have not been fully characterized, particularly in comparison with HF not proximate to medical procedures. This analysis comprises 5,121 men and women free of HF at baseline from the Cardiovascular Health Study who were followed up for 12.0 years (median). HF events were documented by self-report at semi-annual contacts and confirmed by a formal adjudication committee using a review of the participants' medical records and standardized criteria for HF. Incident HF events were additionally adjudicated as either being related or unrelated to a medical procedure (PHF and non-PHF, respectively). We estimated cause-specific hazards ratios for the association of covariates with PHF and non-PHF. There were 1,728 incident HF events in the primary analysis: 168 (10%) classified as PHF, 1,526 (88%) as non-PHF, and 34 unclassified (2%). For those 1,045 participants in whom LV ejection fraction was known at the time of the HF event, it was ≥45% in 89 of 118 participants (75%) with PHF, compared to 517 of 927 participants (55%) with non-PHF (p < 0.001). Increased age, male gender, diabetes, and angina at baseline were associated with both PHF and non-PHF (range of hazard ratios (HR): 1.04-2.05]. Being Black was inversely associated with PHF [HR: 0.46, 95% confidence interval: 0.25-0.86]. Participants with increased age, without baseline angina, and with baseline LVEF<55% were at a significantly lower risk for PHF compared to non-PHF. Among those with PHF, surgical procedures-including cardiac, orthopedic, gastrointestinal, vascular, and urologic-comprised 83.3%, while percutaneous procedures comprised 8.9% (including 6.5% represented by cardiac catheterizations and pacemaker placements). Another group composed of a variety of procedures commonly requiring large fluid volume administration comprised 7.7%. There was a lower all-cause 30-day mortality in the PHF versus the non-PHF group (2.2% vs 5.7%), with a nonsignificant odds ratio of 0.39 in a minimally adjusted model. When individuals with prior myocardial infarction (MI) were excluded in a sensitivity analysis, the proportion of incident HF with concurrent MI was greater for PHF (32.9%) than for non-PHF (19.8%). In conclusion, PHF in older adults is a common entity with relatively low 30-day mortality. Baseline angina, lower age, and LVEF ≥ 55% were associated with a higher risk of PHF compared to non-PHF. Being Black was associated with a lower risk of PHF and PHF as a proportion of HF was lower in Black than in non-Black participants. Compared to non-PHF, PHF more frequently presented with concurrent MI and with preserved LV ejection fraction.
1 aShah, Monali1 aRodriguez, Carlos, J1 aBartz, Traci, M1 aLyles, Mary, F1 aKizer, Jorge, R1 aAurigemma, Gerard, P1 aGardin, Julius, M1 aGottdiener, John, S uhttps://chs-nhlbi.org/node/883702736nas a2200265 4500008004100000022001400041245010700055210006900162260001600231520191100247100002402158700002102182700002402203700001902227700001802246700002502264700001902289700002002308700002402328700001802352700001902370700002102389700002402410856003602434 2021 eng d a1532-541500aUrine creatinine concentration and clinical outcomes in older adults: The Cardiovascular Health Study.0 aUrine creatinine concentration and clinical outcomes in older ad c2021 Aug 073 aPURPOSE: Loss of muscle mass and strength are associated with long-term adverse health outcomes in older adults. Urine creatinine concentrations (Ucr; mg/dl) are a measure of muscle tissue mass and turnover. This study assessed the associations of a spot Ucr level with muscle mass and with risk of hospitalization, mortality, and diabetes mellitus in older adults.
METHODS: We examined 3424 participants from the Cardiovascular Health Study who provided spot urine samples in 1996-1997 and who were followed through June 2015. All participants underwent baseline measurement of grip strength. In a sub-cohort, 1331 participants underwent dual energy X-ray absorptiometry (DEXA) scans, from which lean muscle mass was derived. Participants were followed for a median of 10 years for hospitalizations and mortality, and 9 years for diabetes mellitus.
RESULTS: In linear regression analysis, a one standard deviation higher Ucr concentration (64.6 mg/dl) was associated with greater grip strength (kg force) β = 0.44 [0.16, 0.72]; p = 0.002) and higher lean muscle mass (kg) (β = 0.43 [0.08, 0.78]; p = 0.02). In Cox regression analyses, each standard deviation greater Ucr concentration was associated with lower rates of hospitalizations (0.94 [95% confidence interval, 0.90, 0.98]; p < 0.001) and lower mortality risk (0.92 [0.88, 0.97]; p < 0.001), while a one standard deviation increase in muscle mass derived from DEXA had no such significant association. Ucr levels were not associated with incident diabetes mellitus risk (0.97 [0.85, 1.11]; p = 0.65).
CONCLUSION: A higher spot Ucr concentration was favorably associated with muscle mass and strength and with health outcomes in older community-living adults. The ease of obtaining a spot Ucr makes it an attractive analyte to use for gauging the health of older adults.
1 aBarzilay, Joshua, I1 aBůzková, Petra1 aShlipak, Michael, G1 aLyles, Mary, F1 aBansal, Nisha1 aGarimella, Pranav, S1 aIx, Joachim, H1 aKizer, Jorge, R1 aStrotmeyer, Elsa, S1 aDjoussé, Luc1 aBiggs, Mary, L1 aSiscovick, David1 aMukamal, Kenneth, J uhttps://chs-nhlbi.org/node/8825